Robert J. Kelley - Dec 8, 2021 Form 4 Insider Report for Talis Biomedical Corp (TLIS)

Role
Chief Executive Officer, Director
Signature
/s/ J. Roger Moody, Jr., Attorney-in-Fact for Robert J. Kelley
Stock symbol
TLIS
Transactions as of
Dec 8, 2021
Transactions value $
$0
Form type
4
Date filed
12/9/2021, 03:14 PM
Previous filing
Oct 5, 2021
Next filing
Jun 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLIS Stock Option (right to buy) Award $0 +450K $0.00 450K Dec 8, 2021 Common Stock 450K $4.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.